Shota Yoshida

498 total citations
28 papers, 329 citations indexed

About

Shota Yoshida is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Shota Yoshida has authored 28 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Shota Yoshida's work include Neonatal Respiratory Health Research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Immune Response and Inflammation (4 papers). Shota Yoshida is often cited by papers focused on Neonatal Respiratory Health Research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Immune Response and Inflammation (4 papers). Shota Yoshida collaborates with scholars based in Japan, United States and India. Shota Yoshida's co-authors include Hironori Nakagami, Ryuichi Morishita, Munehisa Shimamura, Hiroki Hayashi, Hiromi Rakugi, Yuka Ikeda, Tomohiro Kawano, Jiao Sun, H. Tomioka and Akiko Tenma and has published in prestigious journals such as Nature Communications, PLoS ONE and Circulation Research.

In The Last Decade

Shota Yoshida

25 papers receiving 327 citations

Peers

Shota Yoshida
Jasper Du United States
Jiao Sun Japan
Avani A. Pendse United States
Sara Bruzzaniti Italy
Annalisa Moregola Italy
Can Tian China
Christian Bauerfeld United States
Jinru Wei China
Erin Naismith Austria
Timm Heinbokel Germany
Jasper Du United States
Shota Yoshida
Citations per year, relative to Shota Yoshida Shota Yoshida (= 1×) peers Jasper Du

Countries citing papers authored by Shota Yoshida

Since Specialization
Citations

This map shows the geographic impact of Shota Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shota Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shota Yoshida more than expected).

Fields of papers citing papers by Shota Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shota Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shota Yoshida. The network helps show where Shota Yoshida may publish in the future.

Co-authorship network of co-authors of Shota Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Shota Yoshida. A scholar is included among the top collaborators of Shota Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shota Yoshida. Shota Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Shota, Hiroki Hayashi, Shunsuke Katsuki, et al.. (2024). A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts. Circulation Research. 136(1). 26–40. 5 indexed citations
2.
3.
4.
5.
Shimamura, Munehisa, Hiroki Hayashi, Shota Yoshida, et al.. (2023). R-spondin 3/LGR4 (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4) Axis Is a Novel Inflammatory and Neurite Outgrowth Signaling System in the Ischemic Brain in Mice. Stroke. 54(6). 1606–1615. 2 indexed citations
6.
Hayashi, Hiroki, Jiao Sun, Tomoyuki Nishikawa, et al.. (2023). Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction. Scientific Reports. 13(1). 13033–13033. 3 indexed citations
7.
Hayashi, Hiroki, Jiao Sun, Shota Yoshida, et al.. (2023). Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats. RMD Open. 9(1). e002851–e002851. 4 indexed citations
8.
Hayashi, Hiroki, Munehisa Shimamura, S. Baba, et al.. (2022). Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice. Scientific Reports. 12(1). 12474–12474. 22 indexed citations
9.
Wakayama, Kouji, Munehisa Shimamura, Shota Yoshida, et al.. (2021). Prevention of vascular dementia via immunotherapeutic blockade of renin-angiotensin system in a rat model. Brain Research. 1772. 147667–147667. 4 indexed citations
10.
Shimamura, Munehisa, Koichi Kaikita, Hironori Nakagami, et al.. (2021). Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey. Scientific Reports. 11(1). 11472–11472. 5 indexed citations
11.
Yoshida, Shota, Chikako Ono, Hiroki Hayashi, et al.. (2021). SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals. Scientific Reports. 11(1). 5934–5934. 19 indexed citations
12.
Hayashi, Hiroki, Munehisa Shimamura, Shota Yoshida, et al.. (2021). Prevention of Acute Lung Injury by a Novel CD14-Inhibitory Receptor Activator of the NF-κB Ligand Peptide in Mice. ImmunoHorizons. 5(6). 438–447. 8 indexed citations
13.
Yoshida, Shota, Hironori Nakagami, Hiroki Hayashi, et al.. (2020). The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature Communications. 11(1). 2482–2482. 106 indexed citations
14.
Shimamura, Munehisa, Hiroki Hayashi, Yuka Ikeda, et al.. (2019). Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis. Scientific Reports. 9(1). 15434–15434. 15 indexed citations
15.
Kawakami, Ryo, Yoichi Nozato, Hironori Nakagami, et al.. (2018). Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice. PLoS ONE. 13(2). e0191895–e0191895. 50 indexed citations
16.
Shimamura, Munehisa, Hironori Nakagami, Hideo Shimizu, et al.. (2018). Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke. Scientific Reports. 8(1). 17770–17770. 15 indexed citations
17.
Yoshida, Shota, et al.. (2018). Effects of the expectorant drug ambroxol hydrochloride on chemically induced lung inflammatory and neoplastic lesions in rodents. Journal of Toxicologic Pathology. 31(4). 255–265. 4 indexed citations
18.
Yokohira, Masanao, et al.. (2017). Validating the use of napsin A as a marker for identifying tumorigenic potential of lung bronchiolo-alveolar hyperplasia in rodents. Experimental and Toxicologic Pathology. 69(8). 637–642. 4 indexed citations
19.
Yokohira, Masanao, et al.. (2016). Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats. Journal of Toxicologic Pathology. 30(2). 153–159. 7 indexed citations
20.
Yokohira, Masanao, et al.. (2016). Chronic mesothelial reaction and toxicity of potassium octatitanate fibers in the pleural cavity in mice and F344 rats. Cancer Science. 107(7). 1047–1054. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasper Du Breakdown of academic impact, for papers by Jiao Sun Breakdown of academic impact, for papers by Avani A. Pendse Breakdown of academic impact, for papers by Sara Bruzzaniti Breakdown of academic impact, for papers by Annalisa Moregola Breakdown of academic impact, for papers by Can Tian Breakdown of academic impact, for papers by Christian Bauerfeld Breakdown of academic impact, for papers by Jinru Wei Breakdown of academic impact, for papers by Erin Naismith Breakdown of academic impact, for papers by Timm Heinbokel
Rankless by CCL
2026